DifGen Pharmaceuticals

DifGen Pharmaceuticals is a US-based global pharmaceutical company specializing in the development and manufacturing of complex, high-barrier-to-entry generic and specialty products. The company focuses on difficult-to-develop dosage forms, including transdermal delivery systems (TDS), oral dissolvable films (ODF), sterile injectables, and ophthalmic suspensions. Through strategic growth and the acquisition of facilities like Aveva Drug Delivery Systems and KriGen Pharmaceuticals, DifGen has established a robust US manufacturing footprint and R&D centers in both the US and India. The company is known for its expertise in navigating complex regulatory pathways and delivering high-quality, affordable alternatives for critical medications in areas such as pain management, addiction, and ophthalmology.